Pruebas
BTA Stat Assay
An immunoassay that detects bladder cancer antigen, which is comprised of various members of the complement factor H-related protein (CFHrp) family, in urine.
Loading
Loading
Busque productos, empresas, pruebas y guías: pase de la consulta a la solicitud de cotización en un solo lugar.
Pruebas
An immunoassay that detects bladder cancer antigen, which is comprised of various members of the complement factor H-related protein (CFHrp) family, in urine.
Pruebas
A CA 19-9 test measures the amount of a protein called CA 19-9 (cancer antigen 19-9) in a sample of your blood. CA 19-9 is a type of tumor marker. Tumor markers are substances made by cancer cells or by normal cells in response to cancer .
Indicadores
An antigen expressed by tissues derived from mullerian epithelium (tubal, endometrial and endocervical) or celomic epithelium (mesothelial cells of the pleura, pericardium and peritoneum). Although its biochemical nature has not been clearly defined, CA125 has been described as a glycosylated, high-molecular-weight protein that may be released from damaged cells. Measurable in plasma, CA125 is a sensitive, nonspecific tumor marker for ovarian cancer; as such it is much more useful for monitoring clinical responses to the treatment of ovarian cancer than for the diagnosis of ovarian cancer. Elevated plasma CA125 may occur in association with other malignancies and non-malignant gynecologic disorders. (NCI04)
Pruebas
This test measures the amount of a protein called CA-125 (cancer antigen 125) in a sample of your blood. CA-125 is a type of tumor marker. Tumor markers are substances that are often made by cancer cells or by normal cells in response to cancer.
Indicadores
CA 19-9 is a fucosylated glycosphingolipid carbohydrate antigen that is soluble and is adsorbed to erythrocytes and to many adenocarcinomas of the digestive tract, especially pancreatic tumors. By structure CA 19-9 is related to the Lewis blood group antigens.
Pruebas
The determination of the amount of the cancer antigen 1 in a sample.
Pruebas
The determination of the amount of cancer antigen 19-9 present in a sample.
Pruebas
The determination of the amount of cancer antigen 242 in a sample.
Pruebas
The determination of the cancer antigen 50 in a sample.
Pruebas
The determination of the amount of the cancer antigen 72-4 present in a sample.
Indicadores
A cancer-specific antigen associated with both tumors and the developing fetus. The main use of this antigen is as a tumor marker, especially with respect to intestinal cancers. Production of the antigen ceases shortly before birth, but may reappear in people who develop certain types of cancer.
Pruebas
The determination of the amount of carcinoembryonic antigen present in a sample.